For over a decade, Baidu founder Robin Li has been the loneliest evangelist of China’s artificial intelligence revolution. While rivals Tencent and Alibaba focused on the lucrative spoils of the mobile internet, Li steered Baidu toward the high-risk, high-reward horizons of deep learning and autonomous systems. Now, in 2026, that long-term gamble is reaching a critical inflection point as three of the tech giant’s most significant offshoots—Kunlun Chip, BioMap, and the streaming giant iQIYI—prepare for a collective capital market debut in Hong Kong.
This flurry of confidential filings represents a strategic unbundling of Baidu’s AI empire. Kunlun Chip, the hardware backbone of Baidu’s 'chip-to-cloud' integration, is the crown jewel of this trio, recently securing massive contracts with China Mobile and traditional banking giants. Despite its robust revenue growth, the semiconductor unit faces a skeptical market that often favors 'pure-play' GPU startups over conglomerate-linked hardware arms, leaving its valuation trailing behind more agile domestic rivals.
In the realm of life sciences, BioMap represents Li’s personal vision for 'AI+Science.' Co-founded by the chairman himself, the company has built one of the world's largest life-science foundation models, attracting strategic partnerships with global pharmaceutical leaders like Sanofi. However, BioMap enters the public sphere as the global appetite for pre-revenue biotech firms cools, forcing investors to weigh the company’s technical prowess against the grueling timelines of clinical validation.
Meanwhile, the proposed secondary listing of iQIYI in Hong Kong signals a different kind of urgency. Once the 'Netflix of China,' iQIYI is now pivoting toward 'AI-generated content' to mask a worrying decline in subscriber growth and cash reserves. By integrating AI agents into the production pipeline, management hopes to slash costs and revive a stock that has shed nearly 90% of its value since its initial US debut, making this IPO a necessary lifeline rather than a victory lap.
Underpinning these financial maneuvers is the persistent paradox of Baidu itself. Long regarded as the 'Whampoa Military Academy' of Chinese AI, the company has trained a generation of talent that has since left to build the very unicorns now competing for Baidu’s market share. This exodus of senior executives continues to haunt the company, raising questions about whether Baidu can retain the creative spark needed to dominate the next phase of the AGI race while its legacy search business remains under pressure.